TBXU ETF — Direxion Daily Biotech Top 5 Bull 2X ETF

Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)

Updated October 16, 2026.

TBXU is an ETF linked to Biotech Top 5. its distribution rate is 1.47%, its trailing-12-month yield is 1.98%, its expense ratio is 0.98%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 48.4% over the past year, 33.0 points ahead of SPY at 15.4%.

Direxion Daily Biotech Top 5 Bull 2X ETF is a leveraged equity ETF that seeks to deliver twice the daily return of the Biotech Top 5 index through swap agreements, direct holdings, and other financial instruments; it is non-diversified and designed for tactical trading rather than long-term holding. The fund carries a modest expense ratio and does not have a regular distribution schedule. This ETF appeals to active traders and investors seeking amplified short-term exposure to the largest biotechnology companies, though the 2X daily leverage makes it suitable only for those with high risk tolerance and experience with leveraged products.

TBXU performance versus SPY

Price and return data through 2026-10-16.

Total return is 48.4% over the past year, 33.0 points ahead of SPY at 15.4%. Its deepest 1-year drawdown was 26.5%.

TBXU key facts

Distribution Safety Score™

50 · Unproven

Issuer

Direxion

Asset type

ETF

Asset class

Equity

Inception date

09/30/2025

Expense ratio

0.98%

Distribution rate

1.47%

Distribution frequency

Quarterly

Trailing yield

1.98%

Last close

$38.59 (as of 2026-10-16)

AUM

$2,774,535

Average volume

1124.0

Dividend

$0.142

Ex-dividend date

09/22/2026

Payment date

09/29/2026

How Dividend Vision calculates yield and returns

Distribution rate (1.47%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (1.98%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Direxion; Index: Biotech Top 5; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

TBXU risks and drawbacks

TBXU's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 26.5%.

Who may consider TBXU — and who may not

It is a weaker fit for investors who need monthly cash flow (TBXU pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on TBXU

• All tickers starting with T

Tagged: Leverage.

Frequently asked questions

More securities from Direxion.